Skip to main content

Table 2 Candidate driver genes with significantly recurrent somatic mutations in mucinous ovarian tumors

From: Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors

 

Exome cohort

SMG prediction

Validation cohort

Overall

Gene

Mutated samples

Nonsense, frameshift indel, splice

Inframe indel, missense

OncodriveFM

MuSiC q-value

Mutated samples

Nonsense, frameshift indel, splice

Inframe indel, missense

Mutated samples

 

q-value

FCPT

LRT

CT

KRAS

12

0

12

1.34 × 10−13

0

0

0

32

0

33

44/82

TP53

7

1

6

3.66 × 10−11

2.86 × 10−7

1.41 × 10−9

1.17 × 10−12

15

0

15

22/82

BRAF

6

0

6

2.45 × 10−8

7.77 × 10−7

0

6.18 × 10−12

4

0

5

10/82

CDKN2A

5

5

2

0.0043

1.20 × 10−10

0

7.93 × 10−17

5

5

0

10/63

RNF43

5

5

0

4.65 × 10−6

–

0.0009

0.0004

3

2

1

8/65b

ELF3

3

2

1

0.0079

–

0.0003

0.0004

1

1

0

4/65

ARID1A

2

2

0

0.0164

–

0.0933

–

–

–

–

2/24

DCLK1

2

0

2

–

–

0.0569

–

–

–

–

2/24

ERBB3

2

0

3

–

–

0.0014

0.0374

0

0

0

2/43

FBXW7

2

1

1

0.0207

–

–

–

–

–

–

2/24

GNAS a

2

0

2

9.05 × 10−8

–

–

–

3

0

3

5/81

KLF5

2

2

0

0.0164

–

0.0056

0.0536

0

0

0

2/43

LPHN3

2

0

2

0.0493

–

–

–

–

–

–

2/24

LRRK2

2

1

1

0.0997

–

–

–

–

–

–

2/24

TTF1

2

0

2

–

–

0.0569

–

–

–

–

2/24

  1. All non-synonymous mutations in listed genes were validated by Sanger sequencing
  2. CT convolution test, FCPT Fisher’s combined P-value test, LRT likelihood ratio test, SMG significantly mutated gene
  3. aOnly mutations involving the hotspot codon 201 are reported
  4. bIncludes samples from Ryland et al. [8] plus 16 additional samples